Wednesday, Jul 3, 2024 · SEC filings
What the smart money revealed on Jul 3
1,064 insider filings came in. We hid 174 planned (10b5-1) sellers and 762 people whose filings were routine, like grants and tax withholding.
Rapport Therapeutics (RAPP) Director James Healy bought $1.08M
44,032 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Carlyle Credit Solutions CEO and President Justin Plouffe bought $500K
25,342 shares on the open market. Not a grant or an option exercise.
Paychex (PAYX) Director Martin Mucci sold $21.9M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 894,143 shares directly.
nCino (NCNO) Director Jeff Horing sold $4.52M
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 24.87M shares.
Zuora (ZUO) Chief Revenue Officer Robert Traube sold $607K
Not marked as a planned 10b5-1 sale. Sold 45% of the shares they held directly. Still holds 75,753 shares.
Show 7 more real buys
Show 84 more real sales
13F season
Holdings as of Jun 30, 2024 are due Aug 14
54 funds have filed so far. 50 filed for the quarter before.
Biggest real insider buys, Jun 27–Jul 3
Open-market buys by officers and directors, filed in the 7 days up to Jul 3.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.